CRVO
CervoMed Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
CervoMed Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
No changes.
No changes.
No thesis.
Annual filing, covered
10-K parsed · Mar 13 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 13 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for CervoMed Inc..
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for CervoMed Inc..
CervoMed Inc.
1.56
−0.08 · −4.81%
Tall tick = annual report · Source: EDGAR
Linked news
Expected move
No implied move.
| Manager | Value | % base | |
|---|---|---|---|
| Woodline Partners | $2.1M | 39.70% | new |
| Vanguardindex-like | $980,226 | 18.22% | 0.00% |
| Sabby | $771,528 | 14.34% | new |
| Geodeindex-like | $207,520 | 3.86% | −10.01% |
| BlackRockindex-like | $166,920 | 3.10% | +4.23% |
| Manager | Value | % base | |
|---|---|---|---|
| Woodline Partners | $2.1M | 39.70% | new |
| Vanguardindex-like | $980,226 | 18.22% | 0.00% |
| Sabby | $771,528 | 14.34% | new |
| Geodeindex-like | $207,520 | 3.86% | −10.01% |
| BlackRockindex-like | $166,920 | 3.10% | +4.23% |
Bull3
Bear1